DrugPatentWatch Database Preview
Atropine - Generic Drug Details
» See Plans and Pricing
What are the generic sources for atropine and what is the scope of freedom to operate?
Atropine
is the generic ingredient in twenty-two branded drugs marketed by Meridian Medcl Techn, Abbvie, Rafa Labs Ltd, Us Army, Akorn, Alcon Labs Inc, Hospira, Fresenius Kabi Usa, Sebela Ireland Ltd, Scherer Rp, Medpointe Pharm Hlc, Hikma, Alpharma Us Pharms, Gd Searle Llc, Md Pharm, Able, Ani Pharms Inc, Ascot, Bayshore Pharms Llc, Fosun Pharma, Heather, Inwood Labs, Kv Pharm, Lannett, Leading Pharma Llc, Lederle, Mayne Pharma Inc, Mylan, Par Pharm, Parke Davis, Pvt Form, R And S Pharma, Roxane, Sun Pharm Industries, Upsher Smith Labs, Usl Pharma, Valeant Pharm Intl, Watson Labs, Vangard, Superpharm, Halsey, Mylan Institutional, Wyeth Ayerst, and Meridian Medcl, and is included in fifty-three NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-three drug master file entries for atropine. Two suppliers are listed for this compound.
Summary for atropine
| US Patents: | 0 |
| Tradenames: | 22 |
| Applicants: | 44 |
| NDAs: | 53 |
| Drug Master File Entries: | 23 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 49 |
| Clinical Trials: | 259 |
| Patent Applications: | 8 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for atropine |
| DailyMed Link: | atropine at DailyMed |
Recent Clinical Trials for atropine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universiti Sains Malaysia | Phase 2 |
| Cairo University | N/A |
| Fayoum University | Phase 1 |
Pharmacology for atropine
| Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for atropine
US Patents and Regulatory Information for atropine
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
